Blankenship G W
Ophthalmology. 1979 Jan;86(1):69-78. doi: 10.1016/s0161-6420(79)35534-8.
Loss of vision from diabetic retinopathy can result from complications of neovascular proliferation, or frequently, from macular edema secondary to background diabetic retinopathy. Although the benefits of photocoagulation for proliferative diabetic retinopathy have been clarified by the National Eye Institute's collaborative diabetic retinopathy study, those for background diabetic retinopathy with macular edema remain unclear. Several articles have described the visual benefits and reduction of edema following photocoagulation of eyes with background diabetic retinopathy and macular edema, but only Patz's study was prospectively designed utilizing a random assignment of laser treatment for one eye with the other eye remaining untreated. This article reports the two-year results of a similar prospective study in which one eye in each of 39 patients with symmetrical macular edema secondary to background diabetic retinopathy was randomly selected to receive argon laser photocoagulation, while the fellow eye remained untreated.
糖尿病性视网膜病变导致的视力丧失可能源于新生血管增殖的并发症,或者更常见的是,继发于背景性糖尿病性视网膜病变的黄斑水肿。尽管美国国立眼科研究所的糖尿病视网膜病变协作研究已经阐明了光凝治疗增殖性糖尿病性视网膜病变的益处,但对于伴有黄斑水肿的背景性糖尿病性视网膜病变,其益处仍不明确。几篇文章描述了对患有背景性糖尿病性视网膜病变和黄斑水肿的眼睛进行光凝治疗后的视力改善和水肿减轻情况,但只有帕茨的研究是前瞻性设计的,采用随机分配激光治疗一只眼睛,另一只眼睛不治疗。本文报告了一项类似前瞻性研究的两年结果,在该研究中,39例患有继发于背景性糖尿病性视网膜病变的对称性黄斑水肿的患者,每例患者的一只眼睛被随机选择接受氩激光光凝治疗,而另一只眼睛不治疗。